Skip to main content Back to Top

Jordan L. Wulz

William Kernan

JORDAN L. WULZ, PharmD, MPH, BC-ADM ([email protected]) is an Assistant Professor specializing in pain management, public health and ambulatory care with Concordia University Wisconsin’s School of Pharmacy (CUWSOP). Jordan earned his PharmD degree from Palm Beach Atlantic University in West Palm Beach, Florida. He then pursued an MPH degree with Samford University in Birmingham, Alabama, where he also completed a two-year ASHP-accredited residency program in ambulatory care in collaboration with the Jefferson County Department of Public Health. Jordan has also completed a one-year Pain Management and Palliative Care Traineeship through the ASHP Foundation for which he received an ASHP Foundation Excellence in Pharmacy scholarship to support this effort. In addition to his teaching responsibilities, Jordan is a Clinical Pharmacist at Ascension Wisconsin’s Center for Pain Management. As part of this role, Jordan serves on the statewide Ascension Wisconsin Opioid Stewardship Council.

Jordan has been an active member of the ASHP Pain Management and Palliative Care Section Advisory Group (SAG) for the Section of Ambulatory Care Practitioners (SACP) over the last five years, previously serving as Vice Chair and currently serving as Chair of the SAG. Jordan has also completed a two year term on the Ambulatory Care Advisory Board for the ASHP state-affiliate, Pharmacy Society of Wisconsin.


Over the past decade, the practice of ambulatory care pharmacy has continued to advance at unprecedented levels. But certainly not without cause! Ambulatory care pharmacists across the nation, many of whom participate as leaders and active members of the ASHP Section of Ambulatory Care Practitioners, are directly responsible for such advancement.

Our Section has tirelessly advocated not only for current pharmacists, but indeed for the pharmacists of the future. As beneficiaries of the groundbreaking efforts of pharmacists past, it is our duty to continue what our leaders started by ensuring healthcare provider status is the standard rather than the exception, by advocating for appropriate and equitable reimbursement methods for ambulatory care pharmacy services, and by furthering innovation in the various specialty roles in which ambulatory care pharmacists can contribute their expertise to directly improve health outcomes. To this end, I am committed to exploring how we can enhance the scope of ambulatory care residency training to better support our pharmacists of the future who very well likely may find themselves in specialty outpatient clinics (i.e. rheumatology, gastroenterology, neurology, etc.) due to the proliferation of novel biologic medications and hence, a very real need for pharmacy expertise.

I am confident our Section is prepared to rise to the occasion of increasingly novel roles and responsibilities, and will continue to significantly contribute to the expansion of high-value pharmacy services. It truly is an honor to be nominated for this position and it would be my privilege to continue to advance the profession with you as Director-At-Large.